BofA Securities Downgrades IGM Biosciences (IGMS) to Underperform

April 8, 2025 5:40 AM EDT Send to a Friend
BofA Securities analyst Geoff Meacham downgraded IGM Biosciences (NASDAQ: IGMS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login